Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Thursday, 4 July 2019
Page: 340


Mr FALINSKI (Mackellar) (13:46): Tom Mechtersheimer is the founder and executive chairman of neuroCare. NeuroCare is a company that specialises in non-invasive options for mental health, pain management and rehabilitation, using neuromodulation technologies integrated with psychotherapy. Tom is a leader in this fast-growing market and he is clearly making an impact within the industry. He is a Bayview resident. Mackellar is lucky to have someone of his calibre in our community, but his legacy and work span much further than Mackellar. Tom co-founded Regeneus, a stem cell company, as well as prostaCare, a company developing a novel DC ablation based BPH treatment. Today he owns and leads the Passion Innovation Group.

Tom has studied internationally and is a fellow of the Australian Institute of Company Directors. He has vast experience in starting markets from scratch, building successful teams and taking on global ventures. His superb track record and his passion for leadership have enabled Tom to unlock the potential of innovations. I take this opportunity to commend Tom on his excellent innovations in the area of neuropathy and thank him for all the work he has done in this area.